Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

615 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.
Finnigan JP Jr, Rubinsteyn A, Hammerbacher J, Bhardwaj N. Finnigan JP Jr, et al. Oncology (Williston Park). 2015 Dec;29(12):970-2, 974-5. Oncology (Williston Park). 2015. PMID: 26676902 Review. No abstract available.
Dendritic cell immunotherapy.
Sabado RL, Bhardwaj N. Sabado RL, et al. Ann N Y Acad Sci. 2013 May;1284:31-45. doi: 10.1111/nyas.12125. Ann N Y Acad Sci. 2013. PMID: 23651191
Directing dendritic cell immunotherapy towards successful cancer treatment.
Sabado RL, Bhardwaj N. Sabado RL, et al. Immunotherapy. 2010 Jan;2(1):37-56. doi: 10.2217/imt.09.43. Immunotherapy. 2010. PMID: 20473346 Free PMC article. Review.
Dendritic cell-based immunotherapy.
Sabado RL, Balan S, Bhardwaj N. Sabado RL, et al. Cell Res. 2017 Jan;27(1):74-95. doi: 10.1038/cr.2016.157. Epub 2016 Dec 27. Cell Res. 2017. PMID: 28025976 Free PMC article. Review.
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.
Gandhi RT, O'Neill D, Bosch RJ, Chan ES, Bucy RP, Shopis J, Baglyos L, Adams E, Fox L, Purdue L, Marshak A, Flynn T, Masih R, Schock B, Mildvan D, Schlesinger SJ, Marovich MA, Bhardwaj N, Jacobson JM; AIDS Clinical Trials Group A5130 team. Gandhi RT, et al. Vaccine. 2009 Oct 9;27(43):6088-94. doi: 10.1016/j.vaccine.2009.05.016. Epub 2009 May 29. Vaccine. 2009. PMID: 19450647 Free PMC article. Clinical Trial.
Twenty-nine subjects on suppressive antiretroviral therapy were randomized to vaccination with autologous DCs infected with CP-HIV+keyhole limpet hemocyanin (KLH) (arm A, n=14) or CP-HIV+KLH alone (arm B, n=15). ...
Twenty-nine subjects on suppressive antiretroviral therapy were randomized to vaccination with autologous DCs infected with CP-HIV+keyhole l …
In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection.
Lubong Sabado R, Kavanagh DG, Kaufmann DE, Fru K, Babcock E, Rosenberg E, Walker B, Lifson J, Bhardwaj N, Larsson M. Lubong Sabado R, et al. PLoS One. 2009;4(1):e4256. doi: 10.1371/journal.pone.0004256. Epub 2009 Jan 23. PLoS One. 2009. PMID: 19165342 Free PMC article.
CD4 Receptor is a Key Determinant of Divergent HIV-1 Sensing by Plasmacytoid Dendritic Cells.
O'Brien M, Manches O, Wilen C, Gopal R, Huq R, Wu V, Sunseri N, Bhardwaj N. O'Brien M, et al. PLoS Pathog. 2016 Apr 15;12(4):e1005553. doi: 10.1371/journal.ppat.1005553. eCollection 2016 Apr. PLoS Pathog. 2016. PMID: 27082754 Free PMC article.
Apoptotic cells at the crossroads of tolerance and immunity.
Skoberne M, Beignon AS, Larsson M, Bhardwaj N. Skoberne M, et al. Curr Top Microbiol Immunol. 2005;289:259-92. doi: 10.1007/3-540-27320-4_12. Curr Top Microbiol Immunol. 2005. PMID: 15791960 Review.
615 results
Jump to page
Feedback